9-24-20 - JAK2 The Future_ Updates in the Biology and Treatment of Myeloproliferative Neoplasms Published 2021-07-27 Download video MP4 360p Download video MP4 720p Recommendations 55:56 9-17-20 - Connecting the Dots in STL - A reporter’s notebook on trauma/structural racism/outcomes 20:44 Myeloproliferative Neoplasm [Hot Topic] 23:17 Mutations in Myelofibrosis: Which to Test for, When and Why 07:58 Essential Thrombocytosis (ET) | Myeloproliferative Neoplasm (JAK2 Kinase) 11:19 POLYCYTHEMIA VERA Etiology Molecular pathogenesis of JAK2V617F mutation. JAK2 kinase 07:03 JAK2 V617F VAF as a diagnostic and prognostic marker for polycythemia vera and thrombosis risk 01:29 What is a JAK2 mutation? 02:19 What is Essential Thrombocythemia (ET)? 04:29 How I Treat Polycythemia Vera - Alessandro Vannucchi, MD 04:35 The role of JAK2 VAF testing in risk assessment and disease monitoring in MPNs 31:08 FANTASTIC STEM CELLS and Where to Find Them with Shiri Gur-Cohen 09:19 JAK-STAT Signaling Pathway 08:14 Chronic Blood Cancer At 30 | Essential Thrombocytosis | MPN 01:37 Dr. Michaelis Discusses the JAK2 Mutation in MPNs 01:41 The emerging role of menin inhibitors in the treatment of NPM1-mutated and KMT2A-rearranged R/R AML 06:04 What are Myeloproliferative Neoplasms? For Patients & Caregivers from Top MPN Specialist 01:26 Dr. Cervantes on the JAK2 Mutation in Myelofibrosis 02:32 JAK/STAT Pathway: Overview 1:32:46 A Conversation with an MPN Specialist: Old and New JAK Inhibitors 20:03 Myeloproliferative Disorders VOPP Dr. Alex - NCD 1 Bastyr Similar videos 02:34 JAK2 V617F Mutations (Myeloproliferative neoplasms (MPNs)): A blood disorder 04:36 RUXOLITINIB (JAKAVI) Mechanism of action. Pharmacology. JAK2 mutation 02:07 Rationale for JAK Inhibition in PV 28:13 Management of ET 21:33 Therapeutic insights in clonal evolution of MPN to accelerated or blastic phase 46:19 Webinar 3: Digital Pathology - Myeloid Neoplasms 36:27 Shining a Light on MPNs: Myeloproliferative Neoplasms with Dr. Noah Merin 27:38 Biology and Therapy of Eosinophilic MPNs 30:29 Myelofibrosis Treatments in 2024: Treating this RARE, BLOOD Cancer | The Patient Story 20:17 Jenny Ho - Genetic underlying leukemic transformation myeloproliferative neoplasms 1:04:47 Myeloproliferative Neoplasms MPNs Awareness 1:06:53 High Throughput Functional Screening for Precision Medicine Approaches in Hematologic Malignancy 21:24 Experimental therapeutics in MPN: Where is the field going? 1:02:43 Translating Immunoregulatory Approaches into the Clinic | Center for Individualized Medicine, 2023 37:14 Risk-Adapted Treatment in Myelofibrosis: JAK Inhibitors and Novel Combination Therapies 02:04 Upcoming news in the MPN field at ASH 2020 2:56:57 MPN Clinical Trial Updates for Physicians 1:18:23 Stem Cell Transplantation a post ASH 2020 Summary More results